Companies in #Pulmonary Hypertension (PH)
Found 1 company operating in this sector.
Tenax Therapeutics is a specialty pharmaceutical company developing therapies for pulmonary hypertension and other cardiovascular diseases with high unmet medical need. Lead candidate TNX-103 (oral imatinib) is being developed for Pulmonary Hypertension associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), a large and underserved patient population. The company has historically advanced levosimendan (TNX-101) in cardiogenic shock and has presented TNX-103 data at the 2026 ESC Congress.